An innovative carrier for the formulation of amorphous solid dispersion by hot-melt extrusion with no further downstream processes: a case study with indomethacin - IMT Mines Albi-Carmaux Accéder directement au contenu
Article Dans Une Revue Pharmaceutical Development and Technology Année : 2024

An innovative carrier for the formulation of amorphous solid dispersion by hot-melt extrusion with no further downstream processes: a case study with indomethacin

Résumé

The aim of this work was to study the possibility to use SepitrapTM as a carrier for the formulation of amorphous solid dispersions by HME (hot melt extrusion) processing aiming solubility enhancement of poorly water-soluble drugs. SepitrapTM is a microencapsulated powder solubilizer designed to simplify the manufacture of drugs in oral solid forms, not yet tested for this purpose. The performance of SepitrapTM was evaluated in HME processing for amorphous solid dispersions of poorly-water soluble drugs with indomethacin as a model drug. The study was conducted using a twin-screw extruder, two compositions of SepitrapTM and different loads of indomethacin, demonstrating that SepitrapTM could represent a new range of carriers for amorphous solid dispersions for HME processing, reducing necessary downstream steps such as grinding
Fichier principal
Vignette du fichier
An-innovative-carrier-formulation-amorphous-solid-dispersion-hot-melt-extrusion.pdf (1.49 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04412951 , version 1 (02-02-2024)

Identifiants

Citer

Suenia de Paiva Lacerda, Sylvie del Confetto, L. Haurie, M. Bernard, S. Faget, et al.. An innovative carrier for the formulation of amorphous solid dispersion by hot-melt extrusion with no further downstream processes: a case study with indomethacin. Pharmaceutical Development and Technology, 2024, 29, pp.131-142. ⟨10.1080/10837450.2024.2306802⟩. ⟨hal-04412951⟩
57 Consultations
36 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More